Page 114 - 《中国药房》2022年6期
P. 114
[ 5 ] BÖHM R,BULIN C,WAETZIG V,et al. Pharmacovigi- disciplinary approach to manage an emerging challenge in
lance-based drug repurposing:the search for inverse sig- Hodgkin lymphoma therapy[J]. Cancers(Basel),2021,13
nals via OpenVigil identifies putative drugs against viral (23):6125.
respiratory infections[J]. Br J Clin Pharmacol,2021,87 [11] LEE K A,SHEPHERD S,BATTISTI N,et al. Ado-trastu-
(11):4421-4431. zumab emtansine-associated spider naevi in metastatic
[ 6 ] PENG L,XIAO K,OTTAVIANI S,et al. A real-world dis- HER2-positive breast cancer[J]. J Case Rep,2019,8(4):
proportionality analysis of FDA adverse event reporting 229-296.
system(FAERS)events for baricitinib[J]. Expert Opin [12] TUDESQ J J,VINCENT L,LEBRUN J,et al. Cytomega-
Drug Saf,2020,19(11):1505-1511. lovirus infection with retinitis after brentuximab vedotin
+
[ 7 ] 宋敏,张子雨,张宏伟,等.基于 FAERS 数据库的伊布替 treatment for CD30 lymphoma[J]. Open Forum Infect Dis,
尼不良事件信号挖掘研究[J].肿瘤药学,2021,11(4): 2017,4(2):ofx091.
406-412. [13] JOSHI A M,PROUSI G S,BIANCO C,et al. Microtubule
[ 8 ] 黄佳,钟薇,王浩,等.基于美国 FAERS数据库的恩美曲 inhibitors and cardiotoxicity[J]. Curr Oncol Rep,2021,23
妥珠单抗不良事件信号挖掘与分析[J].中国医院药学杂 (3):30.
志,2022,42(1):49-53. [14] CURIGLIANO G,LENIHAN D,FRADLEY M,et al.
[ 9 ] FORCE J,SAXENA R,SCHNEIDER B P,et al. Nodular Management of cardiac disease in cancer patients through-
regenerative hyperplasia after treatment with trastuzumab out oncological treatment:ESMO consensus recommenda-
emtansine[J]. J Clin Oncol,2016,34(3):e9-e12. tions[J]. Ann Oncol,2020,31(2):171-190.
[10] VELASCO R,DOMINGO-DOMENECH E,SUREDA A. (收稿日期:2022-01-14 修回日期:2022-02-22)
Brentuximab-induced peripheral neurotoxicity:a multi- (编辑:邹丽娟)
(上接第739页) pertension before and after operation[J]. Clin Pediatr(Phi-
[18] 胡永狮,陈红,管云枫,等.神香苏合丸对狗冠状动脉两步 la),2021,60(1):56-63.
结扎法急性心肌梗塞的影响[J].中国现代应用药学, [25] 薛增明,李雅超,杨彦立,等.麝香保心丸联合尼可地尔对
2000,17(2):99-101. 心绞痛后冠脉微循环障碍患者的疗效及一氧化氮、血管
[19] 朱晓宇,刘洪翠,俞航萍,等.神香苏合丸防治心血管疾病 紧张素Ⅱ、内皮素-1、C-反应蛋白的变化研究[J].辽宁中
的实验研究[J].浙江理工大学学报(自然科学版),2016, 医杂志,2020,47(6):112-114.
35(4):630-635. [26] HAN W X,WEI Z J,DANG R L,et al. Angiotensin-Ⅱ
[20] 钱承嗣,蒋峻.注射用丹参多酚酸联合曲美他嗪治疗老年 and angiotensin-(1-7)imbalance affects comorbidity of
冠心病心绞痛患者疗效及对炎性因子、血管内皮损伤和 depression and coronary heart disease[J]. Peptides,2020,
血脂的影响[J].中国老年学杂志,2021,41(21):4614- 131:170353.
4617. [27] ANGKANANARD T,ANOTHAISINTAWEE T,MCEVOY
[21] SAITO A,AMIYA E,SOMA K,et al. Fractional exhaled M,et al. Neutrophil lymphocyte ratio and cardiovascular
nitric oxide in adult congenital heart disease[J]. Nitric Oxide, disease risk:a systematic review and meta-analysis[J].
2020,100/101:45-49. Biomed Res Int,2018,2018:2703518.
[22] STARK R J,KOCH S R,CHOI H,et al. Endothelial nitric [28] SHIVA G,GOTTO A M,MASSIMILIANO R,et al.
oxide synthase modulates Toll-like receptor 4-mediated Monocyte-to-HDL-cholesterol ratio as a prognostic marker
IL-6 production and permeability via nitric oxide-indepen- in cardiovascular diseases[J]. J Cell Physiol,2018,233
dent signaling[J]. FASEB J,2018,32(2):945-956. (12):9237-9246.
[23] CHAIKIJURAJAI T,TANG W H W. Reappraisal of in- [29] WU F Q,HE M A,WEN Q,et al. Associations between
flammatory biomarkers in heart failure[J]. Curr Heart Fail variants in IL-33/ST2 signaling pathway genes and coro-
Rep,2020,17(1):9-19. nary heart disease risk[J]. Int J Mol Sci,2014,15(12):
[24] LIU Z,ZHANG M M,HUO Q,et al. Changes in ET-1, 23227-23239.
plasma neuropeptide Y,and CGRP in child patients with (收稿日期:2021-10-22 修回日期:2021-12-16)
congenital heart disease complicated with pulmonary hy- (编辑:舒安琴)
·744 · China Pharmacy 2022 Vol. 33 No. 6 中国药房 2022年第33卷第6期